Login / Signup

Clinical experience with the use of novel cephalosporin/beta-lactamase inhibitor combinations among solid organ transplant recipients.

Puja H NambiarKyle D BrizendineVasilios AthansEric Cober
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2019)
Keyphrases
  • gram negative
  • multidrug resistant
  • escherichia coli
  • klebsiella pneumoniae